ALKBH5 mRNA was recognized as a miR-193a-3 target in both glioma and esophageal squamous cell carcinoma (ESCC), with its 3′UTR being a miR-193a-3p binding site [78, 149]. This evidence concerns the gene ALKBH5 and central nervous system cancer.